Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen
By
Bingxin Cai
Yishan Wang
Wen Ma
Zhenzhen Wu
Tingting Yao
Pei Liu
Linhai Wang
Pingping Zhou
Yilin Li
May 29, 2026
Clinical Scorecard: Assessment of CDO1/CELF4 Methylation Testing for Endometrial Cancer: A Prospective Comparison with Paired Intrauterine Samples
At a Glance
Category Detail
Condition Key Mechanisms CDO1/CELF4 gene methylation analysis (source needed) Target Population Care Setting Gansu Provincial Maternity and Child Care Hospital (source needed)
Key Highlights
CDO1/CELF4 methylation analysis shows high sensitivity and specificity for detecting EC (source needed). No significant difference in diagnostic accuracy between CBC and D&C samples (source needed). Strong positive correlation between CBC and D&C samples for CDO1 and CELF4 tests (source needed). Guideline-Based Recommendations
Diagnosis
Use CDO1/CELF4 methylation tests for detecting EIN and EC (source needed). Management
Consider noninvasive CDO1/CELF4 testing as a triage tool (source needed). Monitoring & Follow-up
Monitor patients with AUB using noninvasive methods (source needed). Risks
Invasive procedures like D&C are associated with discomfort (source needed). Patient & Prescribing Data
Women with abnormal uterine bleeding or suspected endometrial lesions (source needed).
Clinical Best Practices
Implement noninvasive methylation testing in clinical practice (source needed). Utilize CBC samples for CDO1/CELF4 testing (source needed). Related Resources & Content
